Earlier Elderly People in Urban Areas

March 15, 2022 updated by: Rosa Sola, University Rovira i Virgili

Characterization, Creativity, Leadership, and Search for Solutions to Improve the Lifestyles of Earlier Elderly People in Urban Areas

Social innovation in aging needs to bring new ideas and services to meet new social and welfare needs identified in recent years. In our environment, people ≥60 years old accounted for 20% -24% of the population in 2015, and it is expected to increase to ≥30% by 2050.

The objectives of this project are: To characterize the elderly (60 to 74 years) who live independently in urban areas of the province of Tarragona, to actively involve them, through a process of participatory research to generate solutions.

To achieve this goal, it is proposed to make a diagnosis of their health status (lifestyles, risk of malnutrition, and sarcopenia), and conduct focus groups including young seniors from urban areas, and stakeholders, to determine their needs, interests, and barriers for pursuing healthy lifestyles. Based on the information obtained in the diagnosis and focus groups, there will be processes for co-creating solutions based on proposed activities or changes in their immediate environment.

Study Overview

Detailed Description

Social innovation in aging needs to bring new ideas and services to meet new social and welfare needs identified in recent years. In our environment, people ≥60 years old accounted for 20% -24% of the population in 2015, and it is expected to increase to ≥30% by 2050. For the first time in history, most people can aspire to live well beyond the age of 60. On the other hand, the Covid-19 pandemic has severely affected people ≥60 years of age and may make the welfare and health problems of this population more evident, such as unhealthy lifestyles, the risk of malnutrition, and sarcopenia (defined as loss of muscle mass, strength, and function), which leads to significant dependency and quality of life problems. In addition, older people living in urban areas have been severely affected by confinement, and new needs are being generated. To better understand the needs, an innovative element of this project is to involve the elderly-young people (60-74 years) from urban areas in the generation of solutions, which will make these solutions especially adapted to their needs. Therefore increase the adherence to the solutions created, and also the long-term sustainability of the solutions.

The objectives of this project are: To characterize the elderly (60 to 74 years) who live independently in urban areas of the province of Tarragona, to actively involve them, through a process of participatory research to generate solutions.

To achieve this goal, it is proposed to make a diagnosis of their health status (lifestyles, risk of malnutrition, and sarcopenia), and conduct focus groups including young seniors from urban areas, and stakeholders, to determine their needs, interests, and barriers for pursuing healthy lifestyles. Based on the information obtained in the diagnosis and focus groups, there will be processes for co-creating solutions based on proposed activities or changes in their immediate environment. During the co-creation process, the elderly and the 4-helix stakeholders (government, industry, university, and civil society) will be involved.

Study Type

Observational

Enrollment (Anticipated)

77

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tarragona
      • Reus, Tarragona, Spain
        • University Rovira i Virgili
      • Reus, Tarragona, Spain, 43204
        • Institut d'Investigació Sanitaria Pere i Virgili

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 74 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Earlier elderly people living in urban areas. The target population will be recruited from different places in the community, town halls, civic centers, senior citizens' associations, etc.

Description

Inclusion Criteria:

  • People ≥60 years and ≤75 years,
  • That they have informed consent,
  • Living at home (living independently), Community-dwelling early-elderly
  • That they can continue the study,
  • They live in the province of Tarragona

Exclusion Criteria:

  • Failure to comply with the inclusion criteria will be considered an exclusion criterion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk of sarcopenia (muscle strength)
Time Frame: 1 day
Reduction of muscle strength: <27kg in men and <16kg in women measured by a dynamometer
1 day
Diagnosis of sarcopenia (muscle strength)
Time Frame: 1 day
Reduction of muscle strength (<27kg in men and <16kg in women measured by a dynamometer)
1 day
Diagnosis of sarcopenia (muscle mass)
Time Frame: 1 day
Reduction of muscle mass (<20kg in men and <15kg in women measured by bioimpedance)
1 day
Diagnosis of severe sarcopenia (muscle strength)
Time Frame: 1 day
Reduction of muscle strength (<27kg in men and <16kg in women measured by a dynamometer) and
1 day
Diagnosis of severe sarcopenia (muscle mass)
Time Frame: 1 day
Reduction of muscle mass (<20kg in men and <15kg in women measured by bioimpedance)
1 day
Diagnosis of severe sarcopenia (muscle function)
Time Frame: 1 day
Reduction of muscle function (≤0.8 m / s)
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutrition
Time Frame: 1 day

Food frequency questionnaire

(not scale)

1 day
Physical activity
Time Frame: 1 day

International physical activity questionnaire for elderly Low category: non-physical activity or it is not enough to achieve moderate or high category Moderate category: 3 or more days / weeks (vigorous physical activity, at least 25 minutes/day), or 5 or more (moderate physical activity, at least 30 minutes/day), or 5 or more days / weeks of a combination of walking, or moderate-vigorous physical activity (at least 600 METS).

High category: 7 or more days / week of a combination of walking, or moderate-vigorous physical activity (at least 3000 METS).

1 day
Sleep behaviour
Time Frame: 1 day

Pittsburg questionnaire

Pittsburg questionnaire The questionnaire contains a total of 19 questions, grouped into 10 questions. The 19 questions are combined to form seven areas with their corresponding score, each of which shows a range between 0 and 3 points. In all cases, a score of "0" indicates ease, while a score of 3 indicates severe difficulty, within their respective area. The score of the seven areas is finally added to give an overall score, which ranges from 0 to 21 points. "0" indicates ease of sleeping and "21" severe difficulty in all areas.

1 day
Risk of malnutrition
Time Frame: 1 day
Mini Nutritional Assessment 12-14 points: normal nutritional status 8-11 points: risk of malnutrition 0-7 points: malnutrition
1 day
Weight
Time Frame: 1 day
Weight using a balance (kg)
1 day
height
Time Frame: 1 day
Height using a tallimeter (m)
1 day
BMI
Time Frame: 1 day
Using weight (kg) / height (m)2
1 day

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: 1 day
Age in years
1 day
Gender
Time Frame: 1 day
Female or male
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rosa Sola, Dr, University Rovira i Virgili

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Anticipated)

March 31, 2022

Study Completion (Anticipated)

March 31, 2022

Study Registration Dates

First Submitted

February 11, 2022

First Submitted That Met QC Criteria

February 24, 2022

First Posted (Actual)

March 7, 2022

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 15, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe